Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:11 PM
Ignite Modification Date:
2025-12-24 @ 4:11 PM
NCT ID:
NCT01901666
Eligibility Criteria:
Inclusion Criteria:
CML patients on Imatinib therapy for more than 6 months and in remission will be included in the study if there is
1. severe short stature (height SDS \<-3 SD)
2. severe growth deceleration (height velocity \<-2 SD over 12 months)
3. Height \<-2 SD and height velocity \<-1.0 SD over 12 months
4. Height \<-1.5 SD and height velocity \<-1.5 SD over 2 years
Exclusion Criteria:
1. Patients with coexisting systemic illness(e.g. kidney disease, liver disease, celiac disease).
2. Patients of CML not receiving Imatinib therapy as prescribed (poor compliance).
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT01901666
Study Brief:
Protocol Section:
NCT01901666